Orion Genomics is a Second Code™ biotechnology company developing oncology diagnostic products and generating revenue in a hybrid products-services model. Orion’s various proprietary technologies, trademarked as GeneThresher, MethylScope, and MethylScreen, detect both normal and abnormal epigenetic patterns of genes and genomes and are used in various agricultural biotechnology and molecular diagnostic applications.